Trasylol Class Action Lawsuit Filed in Canada After Another Study Confirms Increased Risk of Death

-AboutLawsuits

12/04/2008- A class action lawsuit has been filed in Canada against Bayer involving their heart bypass surgery injection Trasylol. The lawsuit was filed the day after a new study was released confirming that individuals who are given the injection face an increased risk of death.

Trasylol, which is also known as an aprotinin injection, is used to control bleeding during cardiac surgery. However, a number of studies have uncovered that there are several serious Trasylol side effects, including an increased risk of kidney failure, heart attacks, strokes and death.

A new study was released yesterday, which is scheduled to be printed in the January 20, 2009 edition of the Canadian Medical Association Journal, which concludes that the risk of death from Trasylol is higher than other anti-bleeding medications, known as lysine analogues.

The study, which involved the evaluation of data from 49 different randomized clinical trials, was released the day before a panel of advisors to Health Canada, the drug regulatory agency in Canada, were scheduled to meet to review future use of the drug.

A prior study published earlier this year in the New England Journal of Medicine, known as the BART study (Blood Conservation using Antifibrinolytics in Randomized Trial), found that heart bypass patients given Trasylol were 53% more likely to die than those treated with tranexamic acid (Cyklokapron) and aminocaproic acid (Amicar), which are other anti-bleeding drugs.

Bayer suspended marketing of Trasylol in November 2007 after researchers stopped the BART trial in October 2007, before the original date the study was to conclude. The BART trial was stopped after preliminary results demonstrated the substantial risk of death.

In the United States, a full Trasylol recall was issued in May 2008, and any remaining stock of the drug as removed from the market. However, Bayer continues to sell aprotinin in some countries.

The Trasylol class action lawsuit filed in Canada alleges that Bayer failed to adequately warn patients and physicians of the increased risk of serious injury associated with the use of Trasylol when compared to safer alternatives.

Ennis & Ennis, P.A. is representing individuals that have been harmed as a result of Trasylol side effects. If you or a loved one have suffered as a result of Trasylol side effects such as kidney failure, heart attack, or stroke you may be entitled to compensation. For more information about a Trasylol lawsuit, a possible Trasylol recall, or for questions regarding Trasylol class action lawsuits click here for a free, confidential case evaluation.